Kapoor GS - Search Results

1

IDH mutation impairs histone demethylation and results in a block to cell differentiation.

Lu C, Ward PS, Kapoor GS, Rohle D, Turcan S, Abdel-Wahab O, Edwards CR, Khanin R, Figueroa ME, Melnick A, Wellen KE, O'Rourke DM, Berger SL, Chan TA, Levine RL, Mellinghoff IK, Thompson CB. Lu C, et al. Among authors: kapoor gs. Nature. 2012 Feb 15;483(7390):474-8. doi: 10.1038/nature10860. Nature. 2012. PMID: 22343901 Free PMC article.

2

Mitogenic signaling cascades in glial tumors.

Kapoor GS, O'Rourke DM. Kapoor GS, et al. Neurosurgery. 2003 Jun;52(6):1425-34; discussion 1434-5. doi: 10.1227/01.neu.0000065135.28143.39. Neurosurgery. 2003. PMID: 12762887 Review.

3

Receptor tyrosine kinase signaling in gliomagenesis: pathobiology and therapeutic approaches.

Kapoor GS, O'Rourke DM. Kapoor GS, et al. Cancer Biol Ther. 2003 Jul-Aug;2(4):330-42. doi: 10.4161/cbt.2.4.507. Cancer Biol Ther. 2003. PMID: 14508101 Free article. Review.

4

Distinct domains in the SHP-2 phosphatase differentially regulate epidermal growth factor receptor/NF-kappaB activation through Gab1 in glioblastoma cells.

Kapoor GS, Zhan Y, Johnson GR, O'Rourke DM. Kapoor GS, et al. Mol Cell Biol. 2004 Jan;24(2):823-36. doi: 10.1128/MCB.24.2.823-836.2004. Mol Cell Biol. 2004. PMID: 14701753 Free PMC article.

5

Transcriptional regulation of signal regulatory protein alpha1 inhibitory receptors by epidermal growth factor receptor signaling.

Kapoor GS, Kapitonov D, O'Rourke DM. Kapoor GS, et al. Cancer Res. 2004 Sep 15;64(18):6444-52. doi: 10.1158/0008-5472.CAN-04-0256. Cancer Res. 2004. PMID: 15374953

6

EGFR inhibition in glioblastoma cells induces G2/M arrest and is independent of p53.

Kapoor GS, Christie A, O'Rourke DM. Kapoor GS, et al. Cancer Biol Ther. 2007 Apr;6(4):571-9. doi: 10.4161/cbt.6.4.3852. Cancer Biol Ther. 2007. PMID: 17457042 Free article.

7

Activated EGFR signaling increases proliferation, survival, and migration and blocks neuronal differentiation in post-natal neural stem cells.

Ayuso-Sacido A, Moliterno JA, Kratovac S, Kapoor GS, O'Rourke DM, Holland EC, García-Verdugo JM, Roy NS, Boockvar JA. Ayuso-Sacido A, et al. Among authors: kapoor gs. J Neurooncol. 2010 May;97(3):323-37. doi: 10.1007/s11060-009-0035-x. Epub 2009 Oct 24. J Neurooncol. 2010. PMID: 19855928

8

SIRPalpha1 receptors interfere with the EGFRvIII signalosome to inhibit glioblastoma cell transformation and migration.

Kapoor GS, O'Rourke DM. Kapoor GS, et al. Oncogene. 2010 Jul 22;29(29):4130-44. doi: 10.1038/onc.2010.164. Epub 2010 May 17. Oncogene. 2010. PMID: 20473329

9

Sprouty2 Drives Drug Resistance and Proliferation in Glioblastoma.

Walsh AM, Kapoor GS, Buonato JM, Mathew LK, Bi Y, Davuluri RV, Martinez-Lage M, Simon MC, O'Rourke DM, Lazzara MJ. Walsh AM, et al. Among authors: kapoor gs. Mol Cancer Res. 2015 Aug;13(8):1227-37. doi: 10.1158/1541-7786.MCR-14-0183-T. Epub 2015 May 1. Mol Cancer Res. 2015. PMID: 25934697 Free PMC article.

10

Editorial Expression of Concern: SIRPa1 receptors interfere with the EGFRvIII signalosome to inhibit glioblastoma cell transformation and migration.

Kapoor GS, O'Rourke DM. Kapoor GS, et al. Oncogene. 2023 Jun;42(26):2154. doi: 10.1038/s41388-023-02740-4. Oncogene. 2023. PMID: 37264082 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters